Objective and methods: From
Introduction
Although considerable progress has been made in achieving successful repair of congenital heart disease in the neonatal period, application of the strategy of early repair to the neonate with low birth-weight has been hampered by the perception that low birth-weight is in itself an operative risk factor.
Several reports have been published regarding the outcome of neonatal cardiac surgery as a whole. Results of surgery in neonates weighing 2500 g or less are scarce.
A retrospective study was carried out over a 6-year period to evaluate short-and intermediate-term outcome of cardiac surgery under extracorporeal circulation in this particular group of patients. Instead of birth-weights we took the actual weight at the time of surgery which seemed, to us, more relevant. From the start we were aware of the obvious difficulties with this study because of the small number of children and the inhomogenicity of the pathologies involved. Furthermore, finding a 'comparative' group of critically ill patients weighing more than 2500 g but with the same type of pathology seemed illusive. Therefore, the purpose of this study was not to compare the outcome of low birth-weight neonates with the general neonatal population, but to illustrate our experiences with this particular group of patients.
Materials and methods
Among 833 infants having undergone cardiac surgery under extracorporeal circulation between September 1990 and February 1997, 23 patients were identified as weighing 2500 g, or less, at the time of surgery.
Hospital charts were obtained for all patients and were sufficiently detailed to allow collection of the following parameters: sex; gestational age; age at operation; birthweight; weight at operation; pre-operative clinical status; pre-operative therapy; pathology; type of surgery; duration of ECC; aortic cross-clamping and eventual total circulatory arrest, as well as immediate-and medium-term outcomes.
Statistical comparison with x 2 analysis was used in researching eventual risk factors for mortality within the group of low weight infants. Statistical significance was defined as P Ͻ 0.05.
A total of 23 neonates weighing 2500 g or less underwent major cardiac surgery with the use of extracorporeal circulation; 12 males (52%) and 11 females (48%).
The more relevant pre-operative data are detailed in Table 1 .
The diagnoses distribution was: D transposition (7) (1 with coarctation), ventricular septal defect (VSD; 4) (2 with coarctation), critical aortic stenosis (3), tetralogy of Fallot (TOF; 2), aortic arch interruption (IAA; 2), univentricular heart (UVH; 2), atrioventricular canal (1), total abnormal pulmonary venous return (TAPVR; 1) and secundum atrial septal defect (1) .
The gestational age range was 28-40 weeks with a birthweight range of 930-3200 g (mean 2275 g). The age at operation ranged from 1-90 days (mean 24 days) while the weight at that time ranged from 1750 to 2500 g (mean 2232 g).
Two patients had a proven chromosomal aberration (Trisomy 21 and Catch 22), while 2 others with univentricular hearts had right atrial isomerism. These last 2 patients also had associated asplenia. Three patients had to receive coarctectomy (with pulmonary artery banding in 1 case) prior to intracardiac repair.
All the patients were hospitalized pre-operatively in the neonatal intensive care unit; all presented with the signs of cardiopulmonary distress concordant with their main hemodynamic disorder: congestive heart failure with respiratory distress in unrestricted left to right shunts; low cardiac output pattern in left heart obstructive lesions and severe hypoxemia in both right heart obstructive lesions and transpositions.
Except in 1 patient with aortic arch interruption, severe metabolic acidosis could be avoided and no patient had to be ressuscitated prior to operation.
Most patients, however, had to be intensively cared for: 17 were permanently ventilated; 13 received catecholamines; 11 prostaglandins; 5 diuretics and 5 digoxin. Ten were receiving catecholamines and prostaglandins while on a ventilator.
None of the patients exhibited pulmonary complications in relation to prematurity but 4 had to be treated for septicemia prior to operation. Moreover, signs of impaired renal function were present in 2 patients.
Extracorporeal circulation (ECC) management, patient monitoring and anaesthetic protocol are similar to those used in neonates and children weighing more than 2500 g. Anaesthetic protocol involves analgetic anaestesia using high doses of opiates (Sufentanil, Pancuronium) systemic use of corticosteroids (Solumedrol).
Extracorporeal circulation with hypothermia (20-24°C) and hemodilution (haematocrit 20-25%) were used in all patients with standard neonatal circuit and oxygenator (1/4 circuit and Safe Micro/polystan 0.33 m 2 oxygenator with hollow fiber membrane); priming contained, as for all neonates, haemacel, SSPP, irradiated and deleucocytised red blood cells, aprotinin and mannitol. We manufacture our canulae ourselves from thorax drains and nasotracheal aspiration tubes; we mostly use canulae size 8 or 10 Ch for aortic canulation, canulae size 12-14 Ch for double venous canulation and canulae size 18-20 for single venous canulation.
Antegrade cold crystalloid cardioplegia (15 ml/kg) was administered in all patients, except for the patient with univentricular heart (UVH) and pulmonary atresia (PA). During extacorporeal circulation blood gas analyses were done using the alpha stat method. Modified ultrafiltration was systematically performed at the end of extracorporeal circulation. Relevant per-operative and post-operative information is summarized in Table 2 .
In 21 patients a complete repair of their congenital heart defect was realised (91%): in 7 patients with transposition of the great arteries the arterial switch operation was performed; 3 of them had an associated ventricular septal defect (1 Taussig-Bing), which was closed simultaneously. Three patients with aortic stenosis had an open commissurotomy. In 2 cases, however, procedure results were not satisfactory. In these 2 patients the degree of left ventricular fibroelastosis was not well appreciated pre-operatively.
In a patient with classic Tetralogy of Fallot we closed the VSD and placed a short transannular patch (autologous pericardium) to widen the right ventricular outflow tract. A patient with pulmonary atresia of the Tetralogy of Fallot type received, following closure of the ventricular septal defect, a 10 mm diameter pulmonary homograft in an orthotopic position. In 4 patients an isolated ventricular septal defect was closed; 2 patients had a correction of an interrupted aortic arch and ventricular septal defect.
One patient had a closure of an ostium secundum type atrial septal defect and 1 had a correction of an isolated total abnormal pulmonary venous return.
Two patients had palliative procedures (9%). A patient with a univentricular heart and total abnormal pulmonary venous return with pulmonary hypertension had a correction of the total abnormal pulmonary venous return and a banding of the pulmonary artery. A patient with a univentricular heart and pulmonary atresia received a central aortopulmonary shunt.
Results
The mean duration of extracorporeal circulation was 117 min (range 49-285 min) (see Table 2 ). The mean aortic cross-clamping time was 40 min (range 20-92 min). The patient with a univentricular heart and accompanying pulmonary atresia was operated on without aortic cross-clamp- 
Relevant pre-operative patient information; deceased patients are marked in bold. ASD, atrial septal defect; VSD, ventricular septal defect; AVSD, atrioventricular septal defect; TAPVR, total abnormal pulmonary venous return; IAA, interrupted aortic arch; AS, aortic stenosis; UVH, univentricular heart; PA, pulmonary atresia; TOF, Fallot's tetralogy; TGA, transposition of the great arteries; COA, coarctation; PAB, pulmonary artery banding; R, Rashkind: T 21, Down syndrome. Table 2 Post-operative status and follow-up ing. Twelve patients (52%) required total circulatory arrest with deep hypothermia (20°C) (mean duration 19 min; range 3-50 min). All patients were successfully weaned from ECC. Five patients left the OR without sternal closure (22%) (mean duration before closure 3.5 days).
One patient had to be revised for bleeding with tamponade (4%). Five patients died in the intensive care unit (ICU)(22%). Two patients with critical aortic stenosis died of left ventricular failure (fibroelastosis) on the 2nd and 3rd day post-operatively; the patient with UVH and PA who received a central aortopulmonary shunt died of respiratory failure 1 month after surgery. The 2 other deceased patients had both an interrupted aortic arch with ventricular septal defect. One of them died of sepsis. The other benefited from extracorporeal membrane oxygenator because of low cardiac output on the first post-operative day but could never be weaned from the assist device. Autopsy showed that the patient had, in fact, a double outlet left ventricle and that the patch placed to close the ventricular septal defect obstructed the left ventricular outflow tract.
The mean duration of intensive care treatment for the surviving neonates was 17.8 days (range 5-35 days). The mean duration of inotropic support was 6.7 days (range 2-23 days) and of artificial ventilation 10.6 days (range 2-17 days).
Post-operative complications were observed in 19 patients (83%): cardiac failure requiring high inotropic support (13 patients); pneumonia (7); sepsis (7); pneumothorax (6); pulmonary hypertensive crisis (4); acute renal insufficiency requiring dialysis (5); hyperglycemia requiring insulin therapy (3); metabolic acidosis (3) and convulsions (2) . Thrombopenia was present in 2 patients. Only 1 patient (with atrioventricular septal defect) presented a transient atrioventricular bloc.
A x 2 statistical analysis was performed to research risk factors for mortality within the group of patients (Table 3) . Statistically significant were: preoperative metabolic acidosis (P Ͻ 0.03); pre-operative dependency of catecholamines (P Ͻ 0.01) and preoperative renal failure (defined as a serum creatinine concentration of more than 1.2 mg/ dl associated with decreased urinary output) (P Ͻ 0.03). Post-operatively significant risk factors were: resuscitation Statistically significant risk factors for early and late death using univariate x 2 analysis (P Ͻ 0.05). in the intensive care unit on the first postoperative day; renal insufficiency requiring dialysis (P Ͻ 0.004) and high inotropic needs (dobutamin Ͼ 10 mg/kg per min and/or adrenalin therapy) (P Ͻ 0.01). The mean follow-up was 31 months (range 2-80 months). Survival rate at 1 year was 73%, the cumulative chance of patient survival (Kaplan-Meier) is 95% after 1 year and 88% after 2 years. (Fig. 1) . One patient with critical aortic stenosis has a residual aortic stenosis with a gradient of 40 mmHg but is still free from reoperation. The patient with the pulmonary atresia type of Fallot's Tetralogy presented possible signs of degradation of the homograft 1 year after initial surgery, but, up to now, 3 years after the initial operation, has not been reoperated.
We had 2 reinterventions. One patient (transposition plus ventricular septal defect) had to be reoperated for right ventricular outflow tract obstruction due to malalignment of the VSD-patch.
The 1 surviving patient with a univentricular heart was operated on 1 year after the palliative procedure. She presented with retrograde pulmonary hypertension from a massively regurgitant single AV-valve which was replaced by a mechanical valve. At the same time, the first step (bidirectional Glenn) of the future total cavopulmonary correction was done; the PA-banding was left in place. Three weeks later she returned with thrombosis of the valve. Fibrinolysis failed. We replaced the mechanical valve by a biological valve and completed the total cavopulmonary correction but the child died a few days later.
Only 1 patient who had closure of a ventricular septal defect has residual mild chronic dyspnea and requires medical therapy. All other survivors are in excellent clinical condition with no respiratory, neurological or major cardiac deficits at the time of their last visit and are without any medication.
Discussion
The management of low-weight neonates with congenital heart defects is a well-recognised problem. The experience of the New England Regional Infant Cardiac Program showed that low birth-weight was a risk factor for mortality in infants with congenital heart disease and that death occurred mostly within the first few weeks of life [1] .
Several reports have been published reporting that low birth-weight alone is a risk factor that contributes to death during or after cardiac surgery [2] [3] [4] .
Due to the perceived high risk of open heart surgery using cardiopulmonary bypass early in life, critically ill neonates were mostly subjected to a first stage palliative procedure to avoid the use of extracorporeal circulation.
However, critical congenital heart disease may cause progressively more severe and sometimes irreversible secondary organ damage, notably to the heart, lungs and the central nervous system. It also interferes with normal post-natal development, such as myocardial hyperplasia, coronary and pulmonary angiogenesis and alveologenesis. In addition, there is a suggestion of developmental and psychomotor abnormalities in these children [5, 6] . Palliation does not seem to protect babies from these changes. Furthermore, in some infants palliation is ineffective. Corrective surgery becomes the only therapeutic option in these patients.
Rapidly growing clinical experience with reparative cardiac operations in neonates seems to contradict the earlier impression that cardiac surgery under extracorporeal circulation in low-weight infants carries a high risk: early reparative surgery using cardiopulmonary bypass has been recently performed in this group of patients with acceptable mortality (18%) and fair long-term survival [7, 8] . These series involve, however, low birth-weight neonates, and do not specify the actual weight of the neonate at the time of surgery, which is, in our opinion, more relevant.
The early mortality in our series (22%) is, taking into account the severity of the clinical condition of our patients, acceptable. Although the results in neonates weighing less than 2.5 kg are worse when compared to those achieved in patients weighing more (early mortality 7-11%) [4, 7, 8] , results are encouraging. Prolonged efforts to achieve medical stability and promote weight gain may not yield superior results compared with early surgical intervention [8] .
Statistically significant risk factors associated with mortality in our series: are presence of pre-operative metabolic acidosis; type of pathology (univentricular congenital heart disease, aortic stenosis with fibroelastosis and interrupted aortic arch associated with ventricular septal defect); preand post-operative renal insufficiency and high post-operative inotropic needs. Age, low birth-weight and low weight at the time of intervention did not significantly affect the outcome within the group of low weight infants. These results seem to correlate with those of other authors for low (birth) weight infants [7, 8] .
More accurate pre-operative evaluation can influence the mortality rate. In retrospect, the 2 infants who died after surgery for critical aortic stenosis had already very poor prognoses due to the presence of fibroelastosis. One of the patients with IAA and VSD had, in fact, a double outlet left ventricle. The patient died because of malposition of the patch to close the VSD; due to the small size of the heart it was not possible to correct this anatomic diagnosis intraoperatively.
Obvious limitations of our study are the small number of patients and the great variety of congenital heart defects involved. We were unable to compare the results with a matched control group regarding the variety of factors involved. We can state that within the group of low weight infants, low weight itself does not influence mortality rates. Particularly encouraging is the notion that all survivors are in good clinical condition after corrective surgery with no respiratory, neurological or major cardiac deficits. All but 1 of our patients is without medication.
Conclusion
Primary reparative surgery for congenital heart disease offers the opportunity to rectify the underlying defect and to abate the secondary effects developing in other organs, and can be performed with good short-and intermediateterm results even in low weight neonates. Palliative procedures should be reserved for those neonates whose anatomy and physiology are not amenable to biventricular repair. We feel encouraged to persist in a policy of major surgery in neonates with low weight and correctable, or palliable, simple, or complex, congenital heart defects.
